BioSpace News Archive

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities announced the expansion of the Advanced Cell Diagnostics -branded RNAscope™ in situ hybridization portfolio with the release of a RNAscope multiomic workflow for the Standard BioTools Hyperion™ Imaging System.

Kimera® Labs Inc. is pleased to announce the FDA IND (Investigational New Drug) approval of its exosomes in a Phase I/IIa clinical trial.

Lipocine Inc. (NASDAQ: LPCN), today announced positive topline results from a pilot clinical PK bridge study of LPCN 1154 (oral brexanolone) with a comparator, IV brexanolone.

Coya Therapeutics, Inc. today reported results from an open-label proof-of-concept clinical study for COYA 301 in patients with AD.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced its financial results for the first quarter of 2023 and provided a business update.

YS Biopharma Co., Ltd. today announced its PIKA Rabies Vaccine has received Phase 3 clinical trial approval from the Drug Regulatory Authority of Pakistan (“DRAP”).

Labcorp, a leading global life sciences company, announced it entered into an agreement with Providence to expand the longstanding strategic relationship between the two organizations.

Terray Therapeutics today announced the appointment of Sudha Parasuraman, MD, as an Independent Director.

Viking Therapeutics, Inc. today announced positive top-line results from its Phase 2b clinical trial of VK2809, the company’s novel liver-selective thyroid hormone receptor beta agonist, in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH).

AlloVir today announced the appointment of Cintia Piccina, PharmD, MBA, as the company’s Chief Commercial Officer, effective June 12, 2023.